Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion type Assertion NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_head.
- NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion description "[Experimental models and expression studies suggest that anti-vascular endothelial growth factor (VEGF) receptor strategies may be of use in patients with emphysema, whereas anti-HER1-directed strategies may be more useful in patients with pulmonary mucus hypersecretion, as seen in chronic bronchitis and asthma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_provenance.
- NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion evidence source_evidence_literature NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_provenance.
- NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion SIO_000772 17406066 NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_provenance.
- NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion wasDerivedFrom befree-20150227 NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_provenance.
- NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_assertion wasGeneratedBy ECO_0000203 NP771007.RAaVBBSq2RZVxsrTuDYi4OnRMxMGn8luUhdZGjw8cDgr4130_provenance.